Karuna Therapeutics
Overview
Karuna Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel therapies to address neuropsychiatric disorders. Their lead program, KarXT, is aimed at treating schizophrenia with the potential to revolutionize the way the condition is managed.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Karuna Therapeutics in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.